- 专利标题： TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
-
申请号： US13857665申请日： 2013-04-05
-
公开(公告)号： US20130296378A1公开(公告)日： 2013-11-07
- 发明人: Lijun Sun , Weiwen Ying , Junghyun Chae , Teresa Prezewloka , Shijie Zhang , Dinesh U. Chimmanamada , Kevin Paul Foley , Zhenjian Du , Hao Li , David James , Howard P. Ng , Zachary Demko , Dan Zhou , Shuzhen Qin
- 申请人： Lijun Sun , Weiwen Ying , Junghyun Chae , Teresa Prezewloka , Shijie Zhang , Dinesh U. Chimmanamada , Kevin Paul Foley , Zhenjian Du , Hao Li , David James , Howard P. Ng , Zachary Demko , Dan Zhou , Shuzhen Qin
- 申请人地址： US MA Lexington
- 专利权人： SYNTA PHARMACEUTICALS CORP.
- 当前专利权人： SYNTA PHARMACEUTICALS CORP.
- 当前专利权人地址： US MA Lexington
- 主分类号： C07D401/04
- IPC分类号： C07D401/04 ; A61K45/06 ; A61K31/4439 ; C07D401/14
摘要：
The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.
公开/授权文献
- US08835464B2 Triazole compounds that modulate HSP90 activity 公开/授权日：2014-09-16
信息查询
